Market Access Issues Hindering Specialists’ Use of Advanced Systemics in Lupus Nephritis
27 juil. 2023 16h00 HE
|
Spherix Global Insights
Exton, Pennsylvania, July 27, 2023 (GLOBE NEWSWIRE) -- While the approvals of GSK’s Benlysta (belimumab) and Aurinia’s Lupkynis (voclosporin) have provided rheumatologists and nephrologists with...